Document Type : Original Research

Authors

Department of Pathology, Faculty of Medicine, Menoufia University, Shebin El Kom, Egypt

Abstract

Background and Objective: Prostatic carcinoma represents the second most common cancer diagnosed in men worldwide after lung cancer and the fourth common male malignancy in Egypt. Autophagy is a natural process that has both oncogenic and tumor-suppressive activities. This study aims to evaluate the role of Beclin1 and LC3B in prostatic carcinoma.
Methods: This retrospective case-control study was conducted on 110 prostate biopsies divided into two groups (55 prostatic carcinoma, 45 pure benign prostatic hyperplasia (BPH), and 10 BPH with adjacent prostatic carcinoma) retrieved from the archive of the Pathology Department, Faculty of Medicine, Menoufia University, in the period between 2017 and 2020. All cases were stained for Beclin1 and LC3B antibodies.
 Results: There was a highly significant association between higher Beclin1 and LC3B immunoreactivity score and Gleason score (score 8 and 9) (P=0.002 and 0.000, respectively). Moreover, there was a highly significant direct association between Beclin1 and LC3B expression (r=0.52, P=0.000). Also, there was a significant stepwise increase in Beclin1 positivity among the three studied groups starting from BPH to prostatic carcinoma passing through cases of BPH with neighboring tumor (P=0.000).
Conclusion: From the results obtained in the present study, autophagy markers Beclin1 and LC3B were upregulated in prostatic carcinoma. Moreover, both were associated with bad prognostic factors. So, it might be necessary to control autophagy flux in prostatic carcinoma. This might be one of the future therapeutic targets for the management of prostatic carcinoma.

Highlights

  • Autophagy markers Beclin1 and LC3B were upregulated in prostatic carcinoma.
  • Both Beclin1 and LC3B were associated with poor prognostic factors in prostatic carcinoma in the form of high Gleason score and grade group.
  • Normalization of the autophagy process in prostatic carcinoma might be an appropriate therapeutic target.

Keywords

Main Subjects

  1. World Cancer: Globocan 2020: International Agency For Research on Cancer; 2020 [Available from: https://gco.iarc.fr/today/data/factsheets/populations/900-world-fact-sheets.pdf.
  2. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71(1):7-33. [DOI:10.3322/caac.21654] [PMID]
  3. Egypt Cancer: Globocan 2020: International Agency For Research on Cancer 2020 [Available from: https://gco.iarc.fr/today/data/factsheets/populations/818-egypt-fact-sheets.pdf.
  4. Sirousbakht S, Rezakhaniha B. Effect of colonoscopy on prostate-specific antigen; new words about an old subject. International Journal of Cancer Management. 2018;11(7). [DOI:10.5812/ijcm.68919]
  5. Rezakhaniha B, Arian pour N, Siroousbakhat S. Effect of cystoscopy on prostate-specific antigen, new words about old subject. Iran J of Cancer Prevent. 2010;3(4):193-8.
  6. Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell. 2011;147(4):728-41. [DOI:10.1016/j.cell.2011.10.026] [PMID]
  7. Yu L, Chen Y, Tooze SA. Autophagy pathway: Cellular and molecular mechanisms. Autophagy. 2018;14(2):207-15. [DOI:10.1080/15548627.2017.1378838] [PMID] [PMCID]
  8. Cheon SY, Kim H, Rubinsztein DC, Lee JE. Autophagy, Cellular Aging and Age-related Human Diseases. Exp Neurobiol. 2019;28(6):643-57. [DOI:10.5607/en.2019.28.6.643] [PMID] [PMCID]
  9. White E, Mehnert JM, Chan CS. Autophagy, Metabolism, and Cancer. Clin Cancer Res. 2015;21(22):5037-46. [DOI:10.1158/1078-0432.CCR-15-0490] [PMID] [PMCID]
  10. Rybstein MD, Bravo-San Pedro JM, Kroemer G, Galluzzi L. The autophagic network and cancer. Nat Cell Biol. 2018;20(3):243-51. [DOI:10.1038/s41556-018-0042-2] [PMID]
  11. Maiti A, Hait NC. Autophagy-mediated tumor cell survival and progression of breast cancer metastasis to the brain. J Cancer. 2021;12(4):954-64. [DOI:10.7150/jca.50137] [PMID] [PMCID]
  12. Guo JY, Xia B, White E. Autophagy-mediated tumor promotion. Cell. 2013;155(6):1216-9. [DOI:10.1016/j.cell.2013.11.019] [PMID] [PMCID]
  13. Marcucci F, Ghezzi P, Rumio C. The role of autophagy in the cross-talk between epithelial-mesenchymal transitioned tumor cells and cancer stem-like cells. Molecular cancer. 2017;16(1):1-8. [DOI:10.1186/s12943-016-0573-8] [PMID] [PMCID]
  14. Nam RK, Benatar T, Amemiya Y, Sherman C, Seth A. Mir-139 Regulates Autophagy in Prostate Cancer Cells Through Beclin-1 and mTOR Signaling Proteins. Anticancer research. 2020;40(12):6649-63. [DOI:10.21873/anticanres.14689] [PMID]
  15. Negri T, Tarantino E, Orsenigo M, Reid JF, Gariboldi M, Zambetti M, et al. Chromosome band 17q21 in breast cancer: significant association between beclin 1 loss and HER2/NEU amplification. Genes, Chromosomes and Cancer. 2010;49(10):901-9. [DOI:10.1002/gcc.20798] [PMID]
  16. Gong C, Bauvy C, Tonelli G, Yue W, Delomenie C, Nicolas V, et al. Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stem-like/progenitor cells. Oncogene. 2013;32(18):2261-72, 72e 1-11. [DOI:10.1038/onc.2012.252] [PMID] [PMCID]
  17. Vega-Rubín-de-Celis S. The role of Beclin 1-dependent autophagy in cancer. Biology. 2020;9(1):4. [DOI:10.3390/biology9010004] [PMID] [PMCID]
  18. Miracco C, Cevenini G, Franchi A, Luzi P, Cosci E, Mourmouras V, et al. Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions. Hum Pathol. 2010;41(4):503-12. [DOI:10.1016/j.humpath.2009.09.004] [PMID]
  19. van Leenders G, van der Kwast TH, Grignon DJ, Evans AJ, Kristiansen G, Kweldam CF, et al. The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma. Am J Surg Pathol. 2020;44(8):e87-e99.
  20. Eskaros AR, Egloff SAA, Boyd KL, Richardson JE, Hyndman ME, Zijlstra A. Larger core size has superior technical and analytical accuracy in bladder tissue microarray. Laboratory Investigation. 2017;97(3):335-42. [DOI:10.1038/labinvest.2016.151] [PMID]
  21. Abdel-Rahman MH, Agour AA, El-Azab DS. Tissue microarray as a research tool to study non-neoplastic liver diseases. Egyptian Liver Journal. 2014;4(3):69-74. [DOI:10.1097/01.ELX.0000451425.36015.99]
  22. Liu C, Xu P, Chen D, Fan X, Xu Y, Li M, et al. Roles of autophagy‑related genes Beclin‑1 and LC3 in the development and progression of prostate cancer and benign prostatic hyperplasia. Biomedical reports. 2013;1(6):855-60. [DOI:10.3892/br.2013.171] [PMID] [PMCID]
  23. Dawson-Saunders B, Trapp R. Basic and Clinical Biostatistics. Lange Medical Book. Practice-Hall International Inc. 1994.
  24. Cristofani R, Montagnani Marelli M, Cicardi ME, Fontana F, Marzagalli M, Limonta P, et al. Dual role of autophagy on docetaxel-sensitivity in prostate cancer cells. Cell Death Dis. 2018;9(9):889. [DOI:10.1038/s41419-018-0866-5] [PMID] [PMCID]
  25. Baspinar S, Bircan S, Orhan H, Kapucuoglu N, Bozkurt KK. The relation of beclin 1 and bcl-2 expressions in high grade prostatic intraepithelial neoplasia and prostate adenocarcinoma: a tissue microarray study. Pathol Res Pract. 2014;210(7):412-8. [DOI:10.1016/j.prp.2014.02.008] [PMID]
  26. Falasca L, Torino F, Marconi M, Costantini M, Pompeo V, Sentinelli S, et al. AMBRA1 and SQSTM1 expression pattern in prostate cancer. Apoptosis. 2015;20(12):1577-86. [DOI:10.1007/s10495-015-1176-3] [PMID] [PMCID]
  27. Oh SH, Lee DW, Choi YB, Lee YH, Ju JS. Measurement of autophagy flux in benign prostatic hyperplasia in vitro. Prostate Int. 2020;8(2):70-7. [DOI:10.1016/j.prnil.2019.11.004] [PMID] [PMCID]
  28. Ziparo E, Petrungaro S, Marini ES, Starace D, Conti S, Facchiano A, et al. Autophagy in prostate cancer and androgen suppression therapy. Int J Mol Sci. 2013;14(6):12090-106. [DOI:10.3390/ijms140612090] [PMID] [PMCID]
  29. Kondo Y, Kanzawa T, Sawaya R, Kondo S. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer. 2005;5(9):726-34. [DOI:10.1038/nrc1692] [PMID]
  30. Mathew R, Karantza-Wadsworth V, White E. Role of autophagy in cancer. Nat Rev Cancer. 2007;7(12):961-7. [DOI:10.1038/nrc2254] [PMID] [PMCID]
  31. Mathew R, Kongara S, Beaudoin B, Karp CM, Bray K, Degenhardt K, et al. Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev. 2007;21(11):1367-81. [DOI:10.1101/gad.1545107] [PMID] [PMCID]
  32. Paglin S, Hollister T, Delohery T, Hackett N, McMahill M, Sphicas E, et al. A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res. 2001;61(2):439-44.